BlackRock Health Sciences Trust (BME) Balance Sheet
BME balance sheet, 2025
December 31, 2025 · U.S. dollars$570.1M assets = $1.8M liabilities + $568.3M equity
Both columns are drawn to the same scale: what BME owns equals what it owes plus shareholders’ equity. Hover a block for its value.
BME financial health
Descriptive bands, not a rating. Fiscal 2025.
BME balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $273.5M2016 | $570.1M2025 | +8.5%/yr | |
| Total liabilities | $2.8M2016 | $1.8M2025 | −4.8%/yr | |
| Shareholders’ equity | $270.7M2016 | $568.3M2025 | +8.6%/yr | |
| Cash & short-term investments | $8.9M2016 | $4.9M2025 | −6.4%/yr | |
| Total debt | $126,9012016 | $894,3322025 | +24.2%/yr | |
| Net cash (debt) | $8.8M2016 | $4.0M2025 | −$4.8M | |
| Working capital | −$976,2402016 | −$8.0M2023 | −$7.0M | |
| Book value per share | $31.302016 | $43.712025 | +3.8%/yr | |
| Debt / equity | 0.002016 | 0.002025 | 0.00 | |
| Shares outstanding | 8.6M2016 | 13.0M2025 | +4.6%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
BME assets
BME liabilities and equity
BME debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
BME balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $4.9M | $26.6M | $534 | $3,118 | $960 | $211,696 | $501,313 | $26.0M | $14.4M | $8.9M |
| Cash & equivalents | $548 | $71,339 | $534 | $3,118 | $960 | $211,696 | $501,313 | $288 | $959 | $208,857 |
| Short-term investments | $4.9M | $26.5M | $31.4M | $23.9M | $27.8M | $2.51B | $3.7M | $26.0M | $14.4M | $8.7M |
| Receivables | $428,138 | $1.2M | $1.6M | $2.4M | $3.2M | $375,658 | $574,412 | $837,525 | $301,485 | $1.7M |
| Inventory | $0 | $0 | $0 | $0 | $31.0M | $0 | $4.7M | $0 | $0 | $0 |
| Other current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total current assets | $5.3M | $26.6M | −$37,840 | $3,118 | $960 | $409,348 | $1.1M | $837,525 | $301,485 | $1.9M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $569.7M | $773.3M | $594.4M | $603.7M | $645.5M | $553.1M | $452.2M | $354.6M | $334.2M | $269.5M |
| Other non-current assets | $0 | $0 | $1.7M | $2.4M | $3.3M | $1.0M | $1.28B | $72,887 | $91,519 | $2.2M |
| Total assets | $570.1M | $774.6M | $596.1M | $606.1M | $648.8M | $554.6M | $1.73B | $355.5M | $334.6M | $273.5M |
| Liabilities | ||||||||||
| Accounts payable | $211,959 | $493,107 | — | $233,198 | $12.5M | $114,211 | $1.5M | $928,582 | $0 | $393,264 |
| Short-term debt | — | $21,115 | $60,686 | $2,920 | $211,572 | $102,701 | $253,802 | $4,675 | $130,910 | $126,901 |
| Deferred revenue | — | — | — | $230,278 | $12.3M | $11,510 | — | $923,907 | — | — |
| Total current liabilities | — | — | $8.0M | $233,198 | $12.5M | $8.6M | $1.5M | $928,582 | $2.8M | $2.8M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Other long-term liabilities | $1.8M | $3.7M | $8.0M | $5.7M | $10.6M | $8.6M | $6.6M | $2.8M | $10,013 | $2.8M |
| Total liabilities | $1.8M | $6.0M | $8.0M | $5.9M | $23.0M | $8.6M | $93.5M | $2.8M | $2.8M | $2.8M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $357.6M | $942.1M | $417.6M | $424.3M | $390.5M | $339.1M | $1.52B | $253.0M | $231.9M | $211.7M |
| Retained earnings (deficit) | $210.7M | −$173.5M | $170.5M | $175.9M | $235.3M | $206.8M | $117.3M | $99.7M | −$61,330 | $29,892 |
| Treasury stock | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Accumulated other comprehensive income | $210.7M | — | $0 | $175.9M | $235.3M | $206.8M | $154.6M | $99.7M | $100.0M | $59.0M |
| Minority interest | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Total shareholders' equity | $568.3M | $768.6M | $588.1M | $600.2M | $625.8M | $3.02B | $1.64B | $352.7M | $331.9M | $270.7M |
| Key figures | ||||||||||
| Total debt | $894,332 | $299,173 | $60,686 | $2,920 | $211,572 | $102,701 | $253,802 | $4,675 | $130,910 | $126,901 |
| Net cash (debt) | $4.0M | $26.3M | −$60,152 | $198 | −$210,612 | $108,995 | $247,511 | $26.0M | $14.3M | $8.8M |
| Working capital | — | — | −$8.0M | −$230,080 | −$12.5M | −$8.2M | −$444,954 | −$91,057 | −$2.5M | −$976,240 |
| Tangible book value | $568.3M | $768.6M | $588.1M | $600.2M | $625.8M | $3.02B | $1.64B | $352.7M | $331.9M | $270.7M |
| Book value per share | $43.71 | $57.98 | $42.18 | $47.61 | — | — | — | $40.55 | $37.34 | $31.30 |
| Shares outstanding | 13.0M | 13.3M | 13.9M | 12.6M | — | — | — | 8.7M | 8.9M | 8.6M |
| Current ratio | — | — | −0.00 | 0.01 | 0.00 | 0.05 | 0.71 | 0.90 | 0.11 | 0.66 |
| Quick ratio | — | — | 0.20 | 10.17 | 0.25 | 0.07 | 0.71 | 28.87 | 5.35 | 3.73 |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity / assets | 99.7% | 99.2% | 98.7% | 99.0% | 96.4% | 545.3% | 94.6% | 99.2% | 99.2% | 99.0% |
| Jun '26 | Dec '25 | Jun '25 | Dec '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 | Mar '23 | Dec '22 | Sep '22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $19.7M | $4.9M | $39,397 | $26.6M | $1,139 | $1,139 | $534 | $534 | $606 | $606 | $3,118 | $3,118 |
| Cash & equivalents | $361 | $548 | $39,397 | $71,339 | $1,139 | $1,139 | $534 | $534 | $606 | $606 | $3,118 | $3,118 |
| Short-term investments | $19.7M | $4.9M | — | $26.5M | $19.9M | — | $31.4M | $31.4M | $28.1M | $28.1M | $23.9M | $23.9M |
| Receivables | $2.6M | $428,138 | $1.7M | $1.2M | $3.2M | $3.2M | $1.6M | $1.6M | $4.0M | $3.9M | $2.4M | $2.4M |
| Inventory | $0 | $0 | $0 | $0 | $2,930 | $2,930 | $0 | $1 | $3.9M | $3.9M | $0 | $0 |
| Other current assets | $0 | $0 | $19,408 | $0 | $280,107 | $280,107 | $0 | $43,665 | $0 | $0 | $0 | $0 |
| Total current assets | $22.3M | $5.3M | $1.8M | $26.6M | $3.4M | $3.4M | $534 | $1.6M | $606 | $4.0M | $3,118 | $2.4M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $569.7M | $526.9M | $773.3M | $621.7M | $0 | $594.4M | $594.4M | $603.7M | $603.7M | $603.7M | $603.7M |
| Other non-current assets | $552.3M | $0 | $0 | $0 | $84,597 | $621.8M | $1.7M | $82,600 | $4.1M | $75,930 | $2.4M | $75,056 |
| Total assets | $574.6M | $570.1M | $528.6M | $774.6M | $625.3M | $625.3M | $596.1M | $596.1M | $607.8M | $607.8M | $606.1M | $606.1M |
| Liabilities | ||||||||||||
| Accounts payable | $1.6M | $211,959 | $14.3M | $493,107 | $172,784 | — | — | — | $528,073 | $357,904 | $233,198 | $233,198 |
| Short-term debt | $569 | — | $1.4M | $21,115 | $12,844 | $1.0M | $60,686 | $60,686 | $96,188 | $2.6M | $2,920 | $678,815 |
| Deferred revenue | — | — | — | — | — | — | — | — | $431,885 | $431,885 | $230,278 | $230,278 |
| Total current liabilities | $569 | — | $14.3M | — | $172,784 | $9.0M | $60,686 | $8.0M | $528,073 | $10.5M | $233,198 | $5.9M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $3.2M | $1.8M | $6.2M | $3.7M | $8.8M | $0 | $8.0M | $8.0M | $10.4M | $96,188 | $5.9M | $233,198 |
| Total liabilities | $3.2M | $1.8M | $20.5M | $6.0M | $9.0M | $9.0M | $8.0M | $8.0M | $10.5M | $10.5M | $5.9M | $5.9M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $357.6M | $357.6M | $367.2M | $942.1M | $417.6M | $417.6M | $417.6M | $417.6M | $427.8M | $427.8M | $424.3M | $424.3M |
| Retained earnings (deficit) | $213.8M | $210.7M | $140.9M | −$173.5M | $198.6M | $198.6M | $170.5M | $170.5M | $169.4M | $169.4M | $175.9M | $175.9M |
| Accumulated other comprehensive income | — | $210.7M | — | — | $198.6M | $0 | $170.5M | $0 | $169.4M | $169.4M | $175.9M | $0 |
| Total shareholders' equity | $571.5M | $568.3M | $508.1M | $768.6M | $616.3M | $616.3M | $588.1M | $588.1M | $597.2M | $597.2M | $600.2M | $600.2M |
| Key figures | ||||||||||||
| Total debt | $688,351 | $894,332 | $1.4M | $299,173 | $1.0M | $1.0M | $60,686 | $60,686 | $96,188 | $2.6M | $2,920 | $678,815 |
| Net cash (debt) | $19.0M | $4.0M | −$1.4M | $26.3M | −$1.0M | −$1.0M | −$60,152 | −$60,152 | −$95,582 | −$2.6M | $198 | −$675,697 |
| Working capital | $22.3M | — | −$12.5M | — | $3.3M | −$5.6M | −$60,152 | −$6.3M | −$527,467 | −$6.5M | −$230,080 | −$3.6M |
| Tangible book value | $571.5M | $568.3M | $508.1M | $768.6M | $616.3M | $616.3M | $588.1M | $588.1M | $597.2M | $597.2M | $600.2M | $600.2M |
| Book value per share | $44.22 | $43.97 | $39.31 | $57.98 | $44.20 | $44.20 | $42.18 | $42.18 | $42.83 | $42.83 | $43.30 | $43.30 |
| Shares outstanding | 12.9M | 12.9M | 12.9M | 13.3M | 13.9M | 13.9M | 13.9M | 13.9M | 13.9M | 13.9M | 13.9M | 13.9M |
| Current ratio | 39,210.63 | — | 0.12 | — | 19.95 | 0.38 | 0.01 | 0.20 | 0.00 | 0.38 | 0.01 | 0.40 |
| Quick ratio | 39,210.63 | — | 0.12 | — | 18.31 | 0.35 | 25.99 | 0.20 | 7.56 | 0.37 | 10.17 | 0.40 |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity / assets | 99.4% | 99.7% | 96.1% | 99.2% | 98.6% | 98.6% | 98.7% | 98.7% | 98.3% | 98.3% | 99.0% | 99.0% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed December 31, 2025); data from EODHD.
BME financial position
At the end of fiscal 2025 (December 31, 2025), BlackRock Health Sciences had total assets of $570.1 million (down 26.4% from a year earlier), total liabilities of $1.8 million and shareholders' equity of $568.3 million. It held $4.9 million in cash and short-term investments against $0.9 million of debt, a net cash position of $4.0 million. In the latest quarter (ended June 30, 2026) total assets were $574.6 million and equity $571.5 million.
Related: BME income statement, BME cash flow statement, BME key metrics. See the BME stock overview for the latest quote and news.
BME balance sheet FAQ
What are BlackRock Health Sciences's total assets?
BlackRock Health Sciences reported total assets of $570.1 million at the end of fiscal 2025 (December 31, 2025), compared with $774.6 million a year earlier.
How much debt does BlackRock Health Sciences have?
BlackRock Health Sciences had $0.9 million of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 0.00.
How much cash does BlackRock Health Sciences have?
BlackRock Health Sciences held $4.9 million in cash and short-term investments at the end of fiscal 2025; with $0.9 million of debt that is net cash of $4.0 million.
What is BlackRock Health Sciences's book value?
BlackRock Health Sciences's shareholders' equity (book value) was $568.3 million at the end of fiscal 2025, or $43.71 per share.